Cargando…

Contemporary Pharmacologic Management of Heart Failure with Reduced Ejection Fraction: A Review

Heart failure with reduced ejection fraction (HFrEF) is defined as the presence of typical symptoms of heart failure (HF) and a left ventricular ejection fraction ≤ 40%. HFrEF patients constitute approximately 50% of all patients with clinical HF. Despite breakthrough discoveries and advances in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Egbuche, Obiora, Hanna, Bishoy, Onuorah, Ifeoma, Uko, Emmanuela, Taha, Yasir, Ghali, Jalal K., Onwuanyi, Anekwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393599/ https://www.ncbi.nlm.nih.gov/pubmed/31288726 http://dx.doi.org/10.2174/1573403X15666190709185011

Ejemplares similares

Cardiovascular complications in COVID‐19 patients with or without diabetes mellitus
por: Abe, Temidayo, et al.
Publicado: (2020)

Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2021)

Racial differences in cardiopulmonary outcomes of hospitalized COVID-19 patients with acute kidney injury
por: Egbuche, Obiora, et al.
Publicado: (2021)

Contemporary Pillars of Heart Failure with Reduced Ejection Fraction Medical Therapy
por: Rahamim, Eldad, et al.
Publicado: (2021)

Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction
por: Vishram-Nielsen, Julie K. K., et al.
Publicado: (2022)

Impact of Peripheral Arterial Disease on Functional Limitation in Congestive Heart Failure: Results from the National Health and Nutrition Examination Survey (1999–2004)
por: Adesunloye, Bamidele A., et al.
Publicado: (2012)

PRE-EXISTING CARDIOVASCULAR DISEASE, ACUTE KIDNEY INJURY, AND CARDIOVASCULAR OUTCOMES IN HOSPITALIZED BLACKS WITH COVID-19 INFECTION
por: Egbuche, Obiora, et al.
Publicado: (2021)

Emerging Pharmacologic Therapies for Heart Failure With Reduced Ejection Fraction
por: Chaudhary, Ammar G., et al.
Publicado: (2021)

Pharmacological Targets in Chronic Heart Failure with Reduced Ejection Fraction
por: Moloce, Maria-Angela, et al.
Publicado: (2022)

Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction
por: Veenis, Jesse F, et al.
Publicado: (2019)

Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction
por: Stolfo, Davide, et al.
Publicado: (2023)

Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry
por: Kapelios, Chris J, et al.
Publicado: (2021)

Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction
por: Girerd, Nicolas, et al.
Publicado: (2022)

Corrigendum to: Digoxin use in contemporary heart failure with reduced ejection fraction: An analysis from the Swedish Heart Failure Registry
Publicado: (2023)

Role of Ivabradine in Patients with Heart Failure with Preserved Ejection Fraction
por: Nadeem, Muhammad, et al.
Publicado: (2020)

Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
por: Nauta, J. F., et al.
Publicado: (2021)

Facts and numbers on epidemiology and pharmacological treatment of heart failure with preserved ejection fraction
por: Edelmann, Frank
Publicado: (2015)

Practical Pharmacological Treatment of Heart Failure: Does Ejection Fraction Matter Anymore?
por: Chan, Jonathan C. H., et al.
Publicado: (2023)

Eligibility for the 4 Pharmacological Pillars in Heart Failure With Reduced Ejection Fraction at Discharge
por: D'Amario, Domenico, et al.
Publicado: (2023)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Comparison of Computed Tomography derived Fractional Flow Reserve to invasive Fractional Flow Reserve in Diagnosis of Functional Coronary Stenosis: A Meta-Analysis
por: Agasthi, Pradyumna, et al.
Publicado: (2018)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction
por: Campos-Martins, Alexandrina, et al.
Publicado: (2021)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

A practical approach to the guideline‐directed pharmacological treatment of heart failure with reduced ejection fraction
por: Abdin, Amr, et al.
Publicado: (2022)

A Contemporary Systematic Approach to Assessing the Patient with Heart Failure with Reduced Ejection Fraction: Multimodal Noninvasive and Invasive Evaluation
por: Wan, Siu-Hin, et al.
Publicado: (2019)

Contemporary Strategies to Manage High Blood Pressure in Patients with Coexistent Resistant Hypertension and Heart Failure With Reduced Ejection Fraction
por: Lang, Katherine, et al.
Publicado: (2020)

Clinical profile and contemporary management of patients with heart failure with preserved ejection fraction: results from the CHECK-HF registry
por: Uijl, A., et al.
Publicado: (2021)

Treatment of Heart Failure With Normal Ejection Fraction
por: Hamdani, Nazha, et al.
Publicado: (2010)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Vericiguat for Heart Failure with Reduced Ejection Fraction
por: Lombardi, Carlo Mario, et al.
Publicado: (2021)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Management of heart failure with reduced ejection fraction
por: Haydock, Paul M, et al.
Publicado: (2022)

Role of sex on the efficacy of pharmacological and non-pharmacological treatment of heart failure with reduced ejection fraction: A systematic review
por: Sanromán Guerrero, María Ascensión, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t5eht3f7u5ddvkjbqvuaq60nih